Live news related to AMOEBA stock (FR0011051598): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
Amoéba (FR0011051598 - ALMIB) announces that it has conducted a comprehensive field testing program in Brazil, in partnership with Koppert, to evaluat…
Amoéba has announced the successful completion of its capital increase through a private placement, raising €6.67 million from institutional investors…
Amoéba announces the holding of its Ordinary and Extraordinary General Meeting on April 3, 2026. This summons comes in a context where the greentech c…
Amoéba has received its first order from Koppert, the global leader in biocontrol, as part of the distribution agreement signed in June 2025. This ord…
Amoeba stock has significantly advanced this Thursday morning, trading at 1.008 euros, marking a 3.7% increase from the previous day. The stock of the…
Amoéba announces that ANSES has initiated the final phase of the evaluation of its biocontrol product AXPERA, submitted in March 2025. Concurrently, F…
Greentech company Amoéba has released its 2025 annual results, showing an increasing operational deficit of 6.8 million euros compared to 5.7 million …
Lyon-based greentech company Amoéba has won the gold medal at the SIVAL Innovation Contest 2026 for its AXPERA biocontrol solution, according to a pre…
